Findings could help inform policy decisions on how to use vaccines in outbreaks

Tobacco plant-produced vaccine could also be less costly, targeted for the developing world

While doctors have long recommended flu shots for protection, experts weren’t exactly sure how the shots affect pregnancy

Discovery provides potential target for vaccines, treatments

The method is an alternative to needle-and-syringe immunization; with further development, it could eliminate the discomfort of an injection as well as the inconvenience and expense of visiting a flu clinic

Grant brings NYBC scientists one step closer to developing a preventive vaccine ready for first-in-human trials by 2020

PNNL scientist part of Pacific Northwest team that has solved 1,000 protein structures

The vaccine adds three more targets to a human vaccine candidate that showed promise

Researchers are analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr Virus, or EBV

The findings, published online May 18 in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines